Tamsulosin for benign prostatic hyperplasia
Tamsulosin for benign prostatic hyperplasia is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tamsulosin for Benign Prostatic Hyperplasia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______.
Tamsulosin for benign prostatic hyperplasia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______. Accessed March 21, 2023.
Tamsulosin for benign prostatic hyperplasia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______
Tamsulosin for Benign Prostatic Hyperplasia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tamsulosin for benign prostatic hyperplasia
ID - 454992
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454992/all/_________Tamsulosin_for_benign_prostatic_hyperplasia______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -